Ask Onix
Isolated microbes in New Mexico cave reveal survival secrets
Bacteria trapped for millions of years in Lechuguilla Cave have developed resistance to nearly all natural antibiotics, offering scientists a potential blueprint for combating modern superbugs.
Extreme environment breeds unique life
Lechuguilla Cave, located 1,604 feet beneath New Mexico's Chihuahuan Desert, stretches 149 miles with no light and scarce nutrients. The cave's isolated ecosystem forces microbes to adapt through predation or chemical warfare.
"You can travel 16 hours in one direction before reaching the end," said Hazel Barton, professor of geological sciences at the University of Alabama. "Some areas have seen fewer human visitors than the moon's surface."
Antibiotic resistance predates human influence
Researchers discovered that cave bacteria show resistance to 26 of 40 tested antibiotics, including last-resort drugs like daptomycin. The cave's formation six million years ago and its sandstone cap rock prevent any surface contamination.
"Resistance mechanisms likely evolved alongside antibiotics over hundreds of millions of years," Barton explained. "These microbes demonstrate that resistance is part of bacterial natural history."
Microbial warfare drives evolution
A non-pathogenic strain called Paenibacillus sp LC231 displayed resistance to 26 antibiotics. Genome sequencing revealed five previously unknown resistance genes, identical to those in surface bacteria.
"When resources are scarce, microbes become aggressive," Barton noted. "We found specimens producing 38 different antimicrobial compounds, including three novel structures."
Potential solutions to global health crisis
Antimicrobial resistance (AMR) caused 1.14 million deaths in 2021, with projections estimating 39 million deaths by 2050. Cave bacteria may help in two ways:
- Discovering ancient antibiotics that surface bacteria can't resist
- Predicting resistance mechanisms to design more effective drugs
Naowarat Cheeptham's team found cave bacteria in Canada that kill multidrug-resistant E. coli and MRSA, but funding shortages paused research.
Future directions
"Understanding existing resistance mechanisms helps prepare for when new antibiotics face resistance," said Gerard Wright of McMaster University. Scientists hope to develop compounds that block bacterial defenses, similar to how clavulanic acid restores penicillin's effectiveness.
"If we can figure out how microorganisms overcome antibiotics, we can defeat them before they appear in clinics," Barton stated.
